• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎肺部病理学、呼吸机相关性肺损伤(VILI)还是脓毒症诱发的急性呼吸窘迫综合征(ARDS)?基于一例尸检病例及简要综述引发的医疗考量

COVID-19 Pulmonary Pathology, Ventilator-Induced Lung Injury (VILI), or Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)? Healthcare Considerations Arising From an Autopsy Case and Miny-Review.

作者信息

Scendoni Roberto, Gattari Diego, Cingolani Mariano

机构信息

Department of Law, Institute of Legal Medicine, University of Macerata, Macerata, Italy.

Anesthesia and Resuscitation Unit, ASUR Marche AV3, Macerata, Italy.

出版信息

Clin Pathol. 2022 Mar 4;15:2632010X221083223. doi: 10.1177/2632010X221083223. eCollection 2022 Jan-Dec.

DOI:10.1177/2632010X221083223
PMID:35284825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8905213/
Abstract

Acute respiratory distress syndrome (ARDS) caused by coronavirus disease (COVID-19) is a serious complication that requires early recognition. Autopsy reports or biopsies of the lungs in patients with COVID-19 revealed diffuse alveolar damage (DAD) at different stages; the fibrotic phase is usually associated with long-standing severe disease. Care management of hospitalized patients is not easy, given that the risk of incurring a ventilator-induced lung injury (VILI) is high. Additionally, if the patient develops nosocomial infections, sepsis-induced ARDS should be considered in the study of the pathophysiological processes. We present an autopsy case of a hospitalized patient whose death was linked to COVID-19 infection, with the histopathological pattern of advanced pulmonary fibrosis. After prolonged use of non-invasive and invasive ventilation, the patient developed polymicrobial superinfection oh the lungs. After analyzing the individual's clinical history and pulmonary anatomopathological findings, we consider healthcare issues that should lead to an improvement in diagnosis and to more adequate standards of care management among health professionals.

摘要

由冠状病毒病(COVID-19)引起的急性呼吸窘迫综合征(ARDS)是一种需要早期识别的严重并发症。COVID-19患者的尸检报告或肺活检显示在不同阶段存在弥漫性肺泡损伤(DAD);纤维化阶段通常与长期的严重疾病相关。鉴于发生呼吸机诱导性肺损伤(VILI)的风险很高,对住院患者的护理管理并不容易。此外,如果患者发生医院感染,在病理生理过程研究中应考虑脓毒症诱导的ARDS。我们报告一例住院患者的尸检病例,其死亡与COVID-19感染有关,具有晚期肺纤维化的组织病理学特征。在长时间使用无创和有创通气后,该患者发生了肺部多重微生物重叠感染。在分析了该个体的临床病史和肺部解剖病理学发现后,我们思考了一些医疗问题,这些问题应能改善诊断,并使医护人员的护理管理标准更加恰当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fcd/8905213/9393bd55792e/10.1177_2632010X221083223-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fcd/8905213/e74cecd6b9e5/10.1177_2632010X221083223-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fcd/8905213/bc5f98941de6/10.1177_2632010X221083223-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fcd/8905213/09b499b5c2b4/10.1177_2632010X221083223-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fcd/8905213/9393bd55792e/10.1177_2632010X221083223-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fcd/8905213/e74cecd6b9e5/10.1177_2632010X221083223-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fcd/8905213/bc5f98941de6/10.1177_2632010X221083223-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fcd/8905213/09b499b5c2b4/10.1177_2632010X221083223-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fcd/8905213/9393bd55792e/10.1177_2632010X221083223-fig4.jpg

相似文献

1
COVID-19 Pulmonary Pathology, Ventilator-Induced Lung Injury (VILI), or Sepsis-Induced Acute Respiratory Distress Syndrome (ARDS)? Healthcare Considerations Arising From an Autopsy Case and Miny-Review.新型冠状病毒肺炎肺部病理学、呼吸机相关性肺损伤(VILI)还是脓毒症诱发的急性呼吸窘迫综合征(ARDS)?基于一例尸检病例及简要综述引发的医疗考量
Clin Pathol. 2022 Mar 4;15:2632010X221083223. doi: 10.1177/2632010X221083223. eCollection 2022 Jan-Dec.
2
Histopathological features in fatal COVID-19 acute respiratory distress syndrome.COVID-19 急性呼吸窘迫综合征的组织病理学特征。
Med Intensiva (Engl Ed). 2021 Jun-Jul;45(5):261-270. doi: 10.1016/j.medin.2021.02.007. Epub 2021 Feb 27.
3
Tracking the time course of pathological patterns of lung injury in severe COVID-19.追踪严重 COVID-19 中肺损伤的病理模式的时间进程。
Respir Res. 2021 Jan 29;22(1):32. doi: 10.1186/s12931-021-01628-9.
4
[Features of the cell composition of inflammatory infiltrate in different phases of diffuse alveolar lung damage with COVID-19].[新型冠状病毒肺炎所致弥漫性肺泡肺损伤不同阶段炎症浸润的细胞组成特征]
Arkh Patol. 2022;84(3):5-13. doi: 10.17116/patol2022840315.
5
Ventilator-Induced Lung Injury (VILI) in Acute Respiratory Distress Syndrome (ARDS): Volutrauma and Molecular Effects.急性呼吸窘迫综合征(ARDS)中的呼吸机相关性肺损伤(VILI):容积伤与分子效应
Open Respir Med J. 2015 Jun 26;9:112-9. doi: 10.2174/1874306401509010112. eCollection 2015.
6
Acute respiratory distress syndrome: underrecognition by clinicians.急性呼吸窘迫综合征:临床医生认识不足。
J Crit Care. 2013 Oct;28(5):663-8. doi: 10.1016/j.jcrc.2013.05.012. Epub 2013 Jun 24.
7
Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients With COVID-19- and Non-COVID-19-Induced Acute Respiratory Distress Syndrome.COVID-19和非COVID-19所致急性呼吸窘迫综合征患者中纤维化样改变和机化性肺炎模式的危险因素及临床影响
Arch Bronconeumol. 2022 Feb;58(2):183-187. doi: 10.1016/j.arbres.2021.05.023. Epub 2021 Jun 4.
8
[Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].严重急性呼吸综合征与2019冠状病毒病的临床和病理特征比较
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jun 12;43(6):496-502. doi: 10.3760/cma.j.cn112147-20200311-00312.
9
Relationship between Mechanical Ventilation and Histological Fibrosis in Patients with Acute Respiratory Distress Syndrome Undergoing Open Lung Biopsy.接受开胸肺活检的急性呼吸窘迫综合征患者机械通气与组织学纤维化之间的关系
J Pers Med. 2022 Mar 16;12(3):474. doi: 10.3390/jpm12030474.
10
[Treatment of patients with different degree of acute respiratory distress syndrome caused by inhalation of white smoke].[白烟雾吸入致不同程度急性呼吸窘迫综合征患者的治疗]
Zhonghua Shao Shang Za Zhi. 2017 Dec 20;33(12):760-765. doi: 10.3760/cma.j.issn.1009-2587.2017.12.008.

引用本文的文献

1
Association between (ΔPaO2/FiO2)/PEEP and in-hospital mortality in patients with COVID-19 pneumonia: A secondary analysis.新冠肺炎患者(ΔPaO2/FiO2)/PEEP 与院内死亡率的关系:一项二次分析。
PLoS One. 2024 May 31;19(5):e0304518. doi: 10.1371/journal.pone.0304518. eCollection 2024.
2
Leading Pathogens Involved in Co-Infection and Super-Infection with COVID-19: Forensic Medicine Considerations after a Systematic Review and Meta-Analysis.新型冠状病毒肺炎合并感染和重叠感染中的主要病原体:系统评价与Meta分析后的法医学考量
Pathogens. 2023 Apr 27;12(5):646. doi: 10.3390/pathogens12050646.
3
What do we know about pathological mechanism and pattern of lung injury related to SARS-CoV-2 Omicron variant?

本文引用的文献

1
Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020.2020 年哥伦比亚麦德林两家诊所收治的 COVID-19 成年住院患者中的细菌合并感染。
PLoS One. 2021 Jul 13;16(7):e0254671. doi: 10.1371/journal.pone.0254671. eCollection 2021.
2
Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic.新冠后肺纤维化:当前大流行的新型后遗症
J Clin Med. 2021 Jun 1;10(11):2452. doi: 10.3390/jcm10112452.
3
Subacute effusive-constrictive pericarditis in a patient with COVID-19.COVID-19 患者亚急性渗出性缩窄性心包炎。
我们对与 SARS-CoV-2 奥密克戎变异株相关的肺损伤的病理机制和模式了解多少?
Diagn Pathol. 2023 Feb 10;18(1):18. doi: 10.1186/s13000-023-01306-y.
4
NLRP-3 Inflammasome: A Key Target, but Mostly Overlooked following SARS-CoV-2 Infection.NLRP-3炎性小体:一个关键靶点,但在新型冠状病毒感染后大多被忽视。
Vaccines (Basel). 2022 Aug 12;10(8):1307. doi: 10.3390/vaccines10081307.
5
Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components.从肺表面活性剂及其成分看 COVID19 的治疗方法。
Front Immunol. 2022 May 3;13:842453. doi: 10.3389/fimmu.2022.842453. eCollection 2022.
BMJ Case Rep. 2021 Jun 11;14(6):e242443. doi: 10.1136/bcr-2021-242443.
4
COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts.新型冠状病毒肺炎与肺纤维化:肺上皮细胞和成纤维细胞的潜在作用。
Immunol Rev. 2021 Jul;302(1):228-240. doi: 10.1111/imr.12977. Epub 2021 May 24.
5
Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.SARS-CoV-2 与其他病原体合并感染和继发感染的流行率和结局:系统评价和荟萃分析。
PLoS One. 2021 May 6;16(5):e0251170. doi: 10.1371/journal.pone.0251170. eCollection 2021.
6
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline.成人 2019 冠状病毒病(COVID-19)住院患者管理:欧洲呼吸学会临床实践指南。
Eur Respir J. 2021 Apr 15;57(4). doi: 10.1183/13993003.00048-2021. Print 2021 Apr.
7
The pulmonary pathology of COVID-19.COVID-19 的肺部病理学。
Virchows Arch. 2021 Jan;478(1):137-150. doi: 10.1007/s00428-021-03053-1. Epub 2021 Feb 19.
8
Ventilation of coronavirus disease 2019 patients.新冠病毒疾病患者的通气。
Curr Opin Crit Care. 2021 Feb 1;27(1):6-12. doi: 10.1097/MCC.0000000000000793.
9
COVID-19 autopsies: Procedure, technical aspects and cause of fatal course. Experiences from a single-center.COVID-19 尸检:程序、技术方面和致死过程的原因。来自单中心的经验。
Pathol Res Pract. 2021 Jan;217:153305. doi: 10.1016/j.prp.2020.153305. Epub 2020 Nov 28.
10
Bacterial coinfections in COVID-19: an underestimated adversary.COVID-19 中的细菌合并感染:被低估的对手。
Ann Ist Super Sanita. 2020 Jul-Sep;56(3):359-364. doi: 10.4415/ANN_20_03_14.